235 related articles for article (PubMed ID: 28942499)
1. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.
Fujiki H; Sueoka E; Rawangkan A; Suganuma M
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2401-2412. PubMed ID: 28942499
[TBL] [Abstract][Full Text] [Related]
2. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.
Fujiki H; Watanabe T; Sueoka E; Rawangkan A; Suganuma M
Mol Cells; 2018 Feb; 41(2):73-82. PubMed ID: 29429153
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.
Li YJ; Wu SL; Lu SM; Chen F; Guo Y; Gan SM; Shi YL; Liu S; Li SL
Tumour Biol; 2015 Apr; 36(4):2747-61. PubMed ID: 25487615
[TBL] [Abstract][Full Text] [Related]
8. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
11. (‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
Sun X; Song J; Li E; Geng H; Li Y; Yu D; Zhong C
Oncol Rep; 2019 Jul; 42(1):425-435. PubMed ID: 31180522
[TBL] [Abstract][Full Text] [Related]
12. [(-)-Epigallocatechin gallate, the main constituent of Japanese green tea, inhibits tumor promotion of okadaic acid].
Yoshizawa S
Fukuoka Igaku Zasshi; 1996 Oct; 87(10):215-21. PubMed ID: 8940799
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
14. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
Chung SS; Vadgama JV
Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review.
Chaudhuri R; Samanta A; Saha P; Ghosh S; Sinha D
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38243984
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin‑3‑gallate inhibits self‑renewal ability of lung cancer stem‑like cells through inhibition of CLOCK.
Jiang P; Xu C; Zhang P; Ren J; Mageed F; Wu X; Chen L; Zeb F; Feng Q; Li S
Int J Mol Med; 2020 Dec; 46(6):2216-2224. PubMed ID: 33125096
[TBL] [Abstract][Full Text] [Related]
19. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.
Gan RY; Li HB; Sui ZQ; Corke H
Crit Rev Food Sci Nutr; 2018 Apr; 58(6):924-941. PubMed ID: 27645804
[TBL] [Abstract][Full Text] [Related]
20. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.
Tang SN; Singh C; Nall D; Meeker D; Shankar S; Srivastava RK
J Mol Signal; 2010 Aug; 5():14. PubMed ID: 20718984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
